Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cellectis Regulatory Filings 2017

Apr 14, 2017

1190_rns_2017-04-14_37f31179-5342-4b6b-ba25-649331c5a500.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

CORRESP 1 filename1.htm CORRESP

Cellectis S.A.

8, rue de la Croix Jarry

75013 Paris, France

April 14, 2017

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention:
Ms. Mary Beth Breslin
Ms. Ada D. Sarmento

RE: Cellectis S.A.

Registration Statement on Form F-3 (File No. 333-217086)

Ladies and Gentlemen:

In accordance with Rules 460 and 461 under the Securities Act of 1933, as amended, Cellectis S.A. (the “ Registrant ”) hereby requests that the Securities and Exchange Commission (the “ Commission ”) take appropriate action to cause the above-referenced Registration Statement on Form F-3 to become effective on April 19, 2017 at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable. The Registrant also hereby requests a copy of the written order verifying the effective date.

Please contact Boris Dolgonos of Jones Day at (212) 326-3430 if you have any questions concerning the foregoing. Thank you for your attention to this matter.

Very truly yours,
CELLECTIS S.A.
By: /s/ André Choulika
André Choulika
Chief Executive Officer

cc: Boris Dolgonos, Jones Day